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Paraparesis and sciatic pain caused by bilateral sacral solitary fibrous tumors: when the least plausible cause is the diagnosis J.N. Alves, M. Monteiro, A. Vilaça, P. Coutinho, Á. Gil, T. Pimentel, M. Rodrigues
Hospital de Braga, Braga, Portugal
Introduction: Solitary Fibrous Tumors (SFT) are rare softtissue tumors of pleural or, less often, extrapleural location. Although sciatic pain is very common, extraspinal compression of the nerve is extremely rare. Results: A 44-year-old man, healthy apart from a totally resected left pelvic SFT in 2010, presents at the emergency department with bilateral sciatic pain and gait disorder. He had progressive sciatic pain at the right for eleven months, and left for one month, that aggravated walking and sitting. Numbing and tingling of the right foot for 6 months. One month before, he developed constipation and effortful micturition, after a week, paresis of the right foot and leg, and later also his left foot. Neurological examination disclosed an asymmetric paraparesis (Right leg grade 2, left leg grade 4 MRC), normal deep tendon reflexes apart from abolished right aquilian reflex and indifferent right plantar response. He also showed reduced tactile and algic sensation distally in both legs. At this point cauda equina syndrome due to compressive lesion was suspected and spinal MRI was performed. With a normal MRI, an extraspinal cause was pursued, pelvic CT showed bilateral sacroiliac lytic mass lesions. Histology was compatible with bilateral SFT recurrence and the patient was oriented to chemotherapy and radiotherapy. Conclusions: To our knowledge this is the first report of sciatic pain as manifestation of SFT. Progressive compression of the sacral plexus and sciatic nerve in the thigh was responsible for the symptoms and its appropriate investigation allowed the diagnosis. Disclosure: Nothing to disclose Introduction: Leptomeningeal infiltration by monoclonal plasma cells is a rare clinical presentation in patients with multiple myeloma (MM), ocurring in around 1% of such patients. Case report: We report the case of a 70-year-old male patient, diagnosed in early 2012 with Durie-Salmon Stage III A non secretory MM that presented as a sacral plasmacytoma. He underwent radiotherapy, four chemotherapy cycles with cyclophosphamide, bortezomib and dexametasone, followed by autologous bone marrow transplant, with very good response. He relapsed two months later, needing another 6 chemotherapy cycles, with adriamicine, carmustine, cyclophosphamide and melfalane, having good response with disease control (marrow samples with 1.2% plasmocyte count). One week after the last cycle, the patient presented with a progressive encephalopathy, gait abnormalities and a right third cranial nerve palsy. The head CT scan was normal, excluding space occupying or lytic lesions. A lumbar puncture revealed mild pleocytosis (227 leucocytes/microL) with predominantly aberrant plasmocytes (around 96%, CD38+). He was diagnosed with meningeal myelomatosis and started intrathecal chemotherapy. Conclusions: MM presenting as meningeal myelomatosis is a rare neurological entity. It is usually associated with multifocal (and variable) neurological deficits and should be suspected in patients with MM even without evidence of intracranial masses or cranial intraparenchymal infiltration. The treatment options include intrathecal chemotherapy but the prognosis is generally very poor. Disclosure: Nothing to disclose Introduction: The spectrum of multiple myeloma's (MM) neurological manifestations is diverse including mainly the spinal cord compression. The involvement of the peripheral nervous system (PNS) is rare.We report two cases with MM revealed by isolated chronic polyradiculoneuritis (CPRN). Case reports: A 34 year-old woman (1) and a diabetic 66 year-old man (2), were admitted for progressive weakness and numbness of four limbs. Neurological examination showed quadriplegia with areflexia predominantly in the lower limbs. Electromyography and neuromuscular biopsy findings were consistent with demyelinating CPRN. Laboratory tests revealed a monoclonal IgG-lambda antibody. Cerebral spinal fluid examination showed increased protein level with normal cell count. Spinal MRI disclosed an osteolytic lesion the right iliac crest for both patients, associated with multiple locations on the vertebrae, and hepato and splenomagaly in one case 1. The diagnosis of MM was confirmed by the presence of a bone marrow plasma cell infiltration. Search for Bence Jones proteinuria and amyloidosis was negative in case 1. The treatment started with systemic chemotherapy. Discussion: Involvement of the PNS is rare in MM. Axonal sensorimotor polyneuropathies are the most common, and usually associated to the osteosclerotic form. CPRN are exceedingly rare, but frequent with solitary plasmacytoma. The pathophysiology of these neuropathies remains obscure with numerous theories including amyloidosis, ischemia, toxic metabolic factors (circulating abnormal protein) and myelin antibodies. The management of the neuropathy consists in treatment of the tumor. Conclusions: These observations emphasize the need for systematic testing for plasma cell proliferation in patients with unexplained lasting CPRN. Disclosure: Nothing to disclose Introduction: CNS radiation therapy is commonly used to treat a variety of CNS tumors including primary and metastatic tumors of the brain or in an attempt to prevent the development of metastases like in small cell lung cancer. The treatment dose and volume depend on the histology, location and size of the tumor. Radiation administered to treat CNS neoplasms can result in acute, subacute, and delayed neurologic syndromes. Most important in clinical practice is radionecrosis which occurs 1 to 3 years after radiation. Symptoms depend on the location and size of necrotic lesion. Their presentation can mimic tumor recurrence.Cerebral radionecrosis often occurs after focal EBRT or brachytherapy. Methods: This is a case study about 60-years-old man with initially squamous cell carcinoma of the lung in IIIA stage with complete pathologic response on the treatment of primary tumor and disease free survival of 2 years when he developed headaches accompanied by ataxia, right homonymous hemianopia and hemiparesis. Brain MRI revealed brain metastases in cerebellum, left occipital and temporal lobe. The whole brain RT (30Gy: 3Gy/10fr) was delivered with sequentially chemotherapy. Results: The patient had 12 months disease free interval, then the same symptoms in more aggressive form occurred and brain MRI showed focal radionecrosis. Conclusions: RT of the brain can lead to necrosis and the dose which gives a 5% probability of a given late effect 5 year after treatment for whole brain RT is 45Gy. Sometimes necrosis can occur with even lower doses which depends of endogenic factor. Disclosure: Nothing to disclose Introduction: A midbrain lesion is a rare but recognised cause of bilateral ptosis. This presentation in isolation, without vertical gaze involvement, is exceptionally rare, but may herald a sinister aetiology that should not be missed. Methods: Case report of a 68 year old woman. Results: A 68-year-old lady with a history of chronic inflammatory demyelinating polyneuropathy presented with progressive asymmetrical bilateral ptosis, but no change in her limb function. Brain MRI showed a midline midbrain lesion displacing the cerebral aqueduct. Chest CT scan revealed a left upper lobe mass, confirmed histopathologically as a poorly differentiated adenocarcinoma.
Conclusions:
The clinical presentation of isolated bilateral ptosis resulting from a midline mibrain metastasis is rare but important. In this patient's case, it was essential to seek a central cause, even in the context of a plausible peripheral explanation. Disclosure: Nothing to disclose Introduction: Anti-Ri antibodies are onconeural antibodies mainly associated with breast and gynecological cancers and small cell lung carcinoma, being mostly associated with cerebellar degeneration and opsoclonus-myoclonus. Symptom onset often begins prior to the diagnosis of systemic cancer, such that identification of antineuronal antibodies may facilitate diagnosis. Clinical case: Female, 49 years old, with a two-month history of diplopia and gait instability. On examination there was a right convergent squint, horizonto-rotatory nystagmus in lateral gaze and an unstable normal-based gait. Brain MRI was normal except for two small arterial aneurisms. Demyelinating, infective causes, vitamin deficiency, toxic exposure and celiac disease were excluded. CSF flow-cytometry was negative for malignant cells. Autoimmune screening showed positive anti-Ri antibodies, leading to the assumption of paraneoplastic syndrome. Steroid treatment was unsuccessful, and monthly intravenous immunoglobulin was then commenced, with slight improvement. All investigations in search for malignancy were unremarkable, except for breast echography which showed a small nodule in the superiorexternal quadrant of left breast. Breast MRI was subsequently performed, showing two small nodules in the same location. Core biopsy showed invasive ductal carcinoma grade II. The patient was submitted to conservative surgery followed by radiotherapy and chemotherapy, with progressive improvement since surgery and only slight residual gait imbalance. Conclusions: This case illustrates that the diagnosis of paraneoplastic syndromes requires a high level of suspicion. Given the onset of symptoms can pre-date the diagnosis of systemic cancer, a thorough investigation is warranted, as treatment of underlying malignancy is the most effective step in controlling the neurological disorder. Disclosure: Nothing to disclose Introduction: Choroid plexus papilloma (CPP) is a rare, histologically benign intracranial tumor, but may present local recurrence or leptomeningeal dissemination. In adults it's usually located in the fourth ventricle. Clinical manifestations result from increased intracranial pressure or hydrocephalus caused by obstruction of cerebrospinal fluid flow or increased production. We report a case of choroid plexus papilloma of the fourth ventricle with diffuse leptomeningeal seeding. Methods: A 35-year-old woman, with a history of chronic migraine, presented with oppresive headache beginning two months before, and characteristics significantly different from their usual migraine crisis. Physical examination revealed a papilledema. Neuroimaging findings are described, treatment performed and histopathology. Results: Neuroimaging studies showed a space-occupying lesion in the fourth ventricle and cystic lesions scattered throughout the subarachnoid space , affecting supratentorial , infratentorial and spinal regions. Completed resection and histopathology of the tumor, confirmed the origin: CPP, with disseminated metastases. After surgery, the patient is asymptomatic. Radiotherapy will be considered in the future.
The CPP dissemination is a rare event. An appropriate differential diagnosis and histological study are very important, to get a definitive diagnosis.Treatment with complete resection of the tumor is the best procedure and derivation of hydrocephalus, when present, must be considered. Adjuvant chemotherapy and radiotherapy have been demonstrated to increase survival in the treatment of choroid plexus carcinoma and may be indicated for aggressive disease. Disclosure: Nothing to disclose Objectives: The immune status of the patient with postoperative intra-cerebral aseptic granuloma 7 months after the removal of fibrillar-protoplasmic astrocytoma of the right frontal lobe was observed. Methods: We have studied immune status of the patient with the determination of the content of CD4+/8+, CD16+, CD25+, CD38+, CD54+, CD95+, CD150+, antibodies to neuroantigen. Cell counts were measured using immunoenzymometric PAP method. Antibodies to neuroantigen studied by Dechtyarenko T.V. described method.
Results:
We demonstrated a reduction in the immunoregulatory index CD4+/CD8+ to 1.72, significant increase in the absolute content of CD25+ to 719 cell/mcl, a reduction of the content of phagocytizing neutrophils to 1500 cell/mcl, a substantial increase in the absolute content of CD38+ to 754 cell/mcl, a significant increase in the level of antibodies to neuroantigen to 22. The amount of lymphocytes expressing molecule of the adhesion ICAM-1 CD54+ (565 cell/mcl) exceeded the normative indices significantly. We found an increase in the content of oncomarker level such as CD150+ to 712 cell/mcl. Furthermore, a quantity of CD95+ (502 cell/mcl) exceeded the normative indices two-fold. Conclusions: For the first time we carried out a study to investigate the immune status of the patient with postoperative intra-cerebral aseptic granuloma formed 7 months after the removal of low grade astrocytoma of the right frontal lobe. The revealed changes describe the presence of the significant immunosuppressive effects, deep disturbances of the processes of intercellular interaction of immunocompetent cells, increased proapoptotic readiness of cells together with the presence of the expressed autoimmune aggression. Disclosure: Nothing to disclose 
